Every evening, after another day hunting Ebola through Bunia and surrounding villages in the eastern Democratic Republic of the Congo, Dr. Patrick Katabuka stands at his front door and asks the question no doctor should have to ask: Should he go inside to his children?

Americans who have high-risk exposures to Ebola in the current outbreak in Central Africa will have access to an experimental antibody treatment.

But these events also serve as a reminder that outbreaks are rarely controlled by vaccines alone. While vaccines play an important role in reducing the spread of disease, infectious disease outbreaks have historically been brought under control through a combination of public health measures,

The Bundibugyo virus, a little known type, previously had caused just two small outbreaks. Now it’s at the center of a rapidly widening epidemic in Africa.

Five patients have recovered from a rare type of Ebola virus, the head of the World Health Organization said Sunday during a visit to Bunia in eastern Congo, a city at the heart of an outbreak. “Four people will be discharged today and there was one that was discharged the day before yesterday,

Angry residents of a town at the epicenter of the Ebola outbreak in eastern Congo​ attacked and burned a tent that was part of a health center where people are being treated for the virus.

As Ebola spreads in East Africa, the United States is playing a much smaller role than it has in previous outbreaks. That leaves China, an economic powerhouse with epidemic control and biotech expertise, as the next global power that could commit supplies, money and medical workers to the effort.

In one worst-case scenario projected, more than 20,000 cases would occur within three months if only 1 in 5 infected people are identified and isolated within two days.

Dozens of people have died and hundreds have been sickened in an Ebola outbreak centered in the Democratic Republic of the Congo.